GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) is a healthcare company (medical devices) based in the United States. The share price is $82.84, down 0.14% on the day, which values the company at $37.46B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.
Key facts
- Share price
- $82.84−0.14% today
- Market value
- $37.46B
- P/E ratio
- 17.5×last 12 months
- Forward P/E
- 15.1×
- Dividend yield
- 0.17%
- Funk Score
- 52/100
- Against its own history
- About its usual priceusual price $83.51
- 200-week average
- $76.658% above
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
GE HealthCare Technologies Inc. in more detail
GEHC trades at 17.5× its last twelve months' earnings, 15.1× next year's expected earnings, 1.7× sales. Measured against its own history, the price is 1% below what its usual multiples would imply ($83.51) — about its usual price. It sits 8% above its 200-week average of $76.65.
Its Funk Score is 52 out of 100 (financial strength 3.8, profitability 5.1, growth 6.5, value 5.4, each out of 10).
11 of the superinvestors tracked here hold GEHC, including Nelson Peltz (4.7% of the portfolio), Harry Burn (2.4% of the portfolio), Dodge & Cox team (1.7% of the portfolio).
Superinvestors holding GEHC
11 of the investors tracked here report a position in their latest 13F filing.
- Nelson Peltz Trian Fund Management4.67% of portfolio · $197.5M · added · Q2 2026
- Harry Burn Sound Shore Management2.39% of portfolio · $76.6M · added · Q3 2026
- Dodge & Cox team Dodge & Cox1.69% of portfolio · $3.2B · added · Q3 2026
- Bill Nygren Harris Associates (Oakmark)1.31% of portfolio · $981.3M · trimmed · Q2 2026
- Steven Romick First Pacific Advisors (FPA)0.65% of portfolio · $54.8M · added · Q3 2026
- Josef Lakonishok LSV Asset Management0.41% of portfolio · $222.2M · trimmed · Q3 2026
- Richard Pzena Pzena Investment Management0.24% of portfolio · $82.1M · new · Q3 2026
- Mark Boyar Boyar Asset Management0.21% of portfolio · $337.4K · added · Q3 2026
- Temasek Temasek Holdings0.18% of portfolio · $66.6M · trimmed · Q3 2026
- Jeremy Grantham (co-founder) GMO (Grantham, Mayo, Van Otterloo)0.06% of portfolio · $28.7M · added · Q3 2026
- Christopher Bloomstran Semper Augustus0.03% of portfolio · $293.2K · Q2 2026
Health Care companies of similar size
- NateraNTRA
- IQVIA HoldingsIQV
- Revolution MedicinesRVMD
- Royalty PharmaRPRX
- BiogenBIIB
- AlconALC
- Mettler-Toledo InternationalMTD
- CenteneCNC
- GenmabGMAB
- IlluminaILMN
- ResMedRMD
- ZoetisZTS
Side by side:GEHC vs BIIB (GE HealthCare Technologies Inc. vs Biogen)GEHC vs ALC (GE HealthCare Technologies Inc. vs Alcon)GEHC vs RPRX (GE HealthCare Technologies Inc. vs Royalty Pharma)GEHC vs MTD (GE HealthCare Technologies Inc. vs Mettler-Toledo International)GEHC vs CNC (GE HealthCare Technologies Inc. vs Centene)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
GE HealthCare Technologies Inc. (GEHC): questions and answers
What is GEHC's P/E ratio?
GE HealthCare Technologies Inc. trades at 17.5× its last twelve months' earnings and 15.1× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 12.6× to 25.5×, with a median of 18.0×.
What is GEHC's PEG ratio?
GE HealthCare Technologies Inc.'s PEG ratio is 2.22 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is GE HealthCare Technologies Inc.'s market cap?
GE HealthCare Technologies Inc. is valued at $37.46B at a share price of $82.84.
Is GEHC overvalued or undervalued?
Against its own history, GEHC is about its usual price: the price is 1% below the $83.51 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is GEHC above its 200-week moving average?
Yes. GEHC is 8.1% above its 200-week average of $76.65. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is GE HealthCare Technologies Inc. growing?
Over the last three fiscal years GE HealthCare Technologies Inc.'s revenue grew 4.0% a year and its earnings per share -0.6% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “GE HealthCare Technologies Inc. (GEHC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GEHC
Underlying data: Yahoo Finance; company filings with the SEC.